Editas Medicine (EDIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 138,692 | 131,541 | 95,832 | 64,441 | 69,227 |
| Marketable Securities | 82,272 | 138,372 | 169,256 | 214,671 | 226,944 |
| Receivables | 510 | 16,266 | 126 | 244 | 245 |
| TOTAL | $224,843 | $289,315 | $271,139 | $286,354 | $305,555 |
| Non-Current Assets | |||||
| PPE Net | 8,182 | 14,497 | 15,419 | 14,156 | 13,257 |
| Investments And Advances | 0 | 0 | 0 | 39,195 | 80,605 |
| Other Non-Current Assets | 30,627 | 37,777 | 41,009 | 45,096 | 40,930 |
| TOTAL | $38,809 | $52,274 | $56,428 | $98,447 | $134,792 |
| Total Assets | $263,652 | $341,589 | $327,567 | $384,801 | $440,347 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,465 | 5,493 | 12,491 | 13,769 | 7,966 |
| Accrued Expenses | 47,488 | 45,859 | 28,785 | 27,669 | 31,481 |
| Other current liabilities | 5,000 | 5,000 | N/A | N/A | N/A |
| TOTAL | $73,114 | $77,225 | $72,353 | $74,306 | $66,487 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 2,000 | 6,221 | 14,684 | 14,684 | 14,684 |
| Other Non-Current Liabilities | 73,914 | 75,886 | 25,376 | 24,282 | 25,256 |
| TOTAL | $128,118 | $130,090 | $79,580 | $78,486 | $79,460 |
| Total Liabilities | $201,232 | $207,315 | $151,933 | $152,792 | $145,947 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 83,713 | 82,976 | 82,548 | 82,476 | 82,238 |
| Common Shares | 8 | 8 | 8 | 8 | 8 |
| Retained earnings | -1,544,531 | -1,468,443 | -1,423,048 | -1,360,907 | -1,293,300 |
| Other shareholders' equity | 88 | 268 | 522 | -442 | -326 |
| TOTAL | $62,420 | $134,274 | $175,634 | $232,009 | $294,400 |
| Total Liabilities And Equity | $263,652 | $341,589 | $327,567 | $384,801 | $440,347 |